Murrayhill Eye Care

03/07/2026

Not sure this ever will get old. Not sure if it will.

02/23/2026

Take a look at the hinge design and craftsmanship on this eyewear frame. So good. Stop by to see how it looks and feels and works.
Europa Eyewear LINDBERG

02/05/2026

Should be on your must see list. Better to try them on in our office. As much as we all love shopping online, eyewear not so much.
-Dr. Greg
AO Eyewear Europa Eyewear

American Optical's Original Pilot is one of the greatest sunglasses frames of all time.

01/26/2026

Not all eyewear is special. If you want bespoke you owe this a look. Let us know if you are needing more details.

10/28/2025

Amazing what modern medicine is capable of. Just amazing.
-Greg

A 67-year-old man presented with right central retinal artery occlusion (visual acuity: 20/2000) 17 hours after symptom onset and underwent vitrectomy at 20 hours. Cannulation with a 48-gauge microneedle and tissue plasminogen activator (tPA) injection rendered the artery transparent (A). After tPA infusion for 3 minutes, arterial massage was applied using a soft-tip cannula. Subsequently, fragmented emboli migrated toward the peripheral retinal arterioles (B, arrows), a phenomenon observed multiple times. With no bleeding at the puncture site under normal infusion pressure, the procedure was concluded. Preoperative (C) and postoperative day 1 (D) OCT angiography confirmed reperfusion, and visual acuity improved marginally to 20/500. Earlier presentation and intervention may have better visual outcome.

From “Embolus Migration and Reperfusion in Central Retinal Artery Occlusion Treated by Intra-Arterial Cannulation” by Shin Tanaka, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Kazuaki Kadonosono, MD, PhD. Published by Ophthalmology online on August 16, 2025.

https://www.aaojournal.org/article/S0161-6420(25)00446-4/fulltext

10/28/2025

A 67-year-old man presented with right central retinal artery occlusion (visual acuity: 20/2000) 17 hours after symptom onset and underwent vitrectomy at 20 hours. Cannulation with a 48-gauge microneedle and tissue plasminogen activator (tPA) injection rendered the artery transparent (A). After tPA infusion for 3 minutes, arterial massage was applied using a soft-tip cannula. Subsequently, fragmented emboli migrated toward the peripheral retinal arterioles (B, arrows), a phenomenon observed multiple times. With no bleeding at the puncture site under normal infusion pressure, the procedure was concluded. Preoperative (C) and postoperative day 1 (D) OCT angiography confirmed reperfusion, and visual acuity improved marginally to 20/500. Earlier presentation and intervention may have better visual outcome.

From “Embolus Migration and Reperfusion in Central Retinal Artery Occlusion Treated by Intra-Arterial Cannulation” by Shin Tanaka, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Kazuaki Kadonosono, MD, PhD. Published by Ophthalmology online on August 16, 2025.

https://www.aaojournal.org/article/S0161-6420(25)00446-4/fulltext

10/28/2025

Filed under Things I never thought I would see. Glorious, Amen. Dr. Greg

A 67-year-old man presented with right central retinal artery occlusion (visual acuity: 20/2000) 17 hours after symptom onset and underwent vitrectomy at 20 hours. Cannulation with a 48-gauge microneedle and tissue plasminogen activator (tPA) injection rendered the artery transparent (A). After tPA infusion for 3 minutes, arterial massage was applied using a soft-tip cannula. Subsequently, fragmented emboli migrated toward the peripheral retinal arterioles (B, arrows), a phenomenon observed multiple times. With no bleeding at the puncture site under normal infusion pressure, the procedure was concluded. Preoperative (C) and postoperative day 1 (D) OCT angiography confirmed reperfusion, and visual acuity improved marginally to 20/500. Earlier presentation and intervention may have better visual outcome.

From “Embolus Migration and Reperfusion in Central Retinal Artery Occlusion Treated by Intra-Arterial Cannulation” by Shin Tanaka, MD, PhD, Maiko Maruyama-Inoue, MD, PhD, Kazuaki Kadonosono, MD, PhD. Published by Ophthalmology online on August 16, 2025.

https://www.aaojournal.org/article/S0161-6420(25)00446-4/fulltext

08/29/2025

One more reason we prescribe and recommend Carl Zeiss Vision lenses for your glasses. -Dr. Greg

08/29/2025

Okay, it's not about the scans, they are super cool. It's about innovative thinking and advancement. Look out Glaucoma, we are gaining on you. -Dr. Greg

In a recent study, scientists used tiny magnets to steer stem cells into the eye’s drainage system. The result? Lower eye pressure for up to 9 months in lab models, offering hope for a cell-based therapy in the future.

The research is still in early stages, but it’s a big step toward more lasting, less invasive options for glaucoma care.

Read more: https://brnw.ch/21wVhNV

06/24/2025

Come and see for yourself. We have a special event featuring Friday June 27, 2025 from 3pm to 7pm.

11/26/2024

We celebrate Amy's birthday today. Happy Birthday Amy. Oh, she only worked overtime today in support of her patients and her colleague who is out sick. Love us some Amy!-G

11/12/2024

We find your best vision is achieved with the proper prescription filled with precision optics in a well fitted quality frame.

Crafted for your eyes: Get your ZEISS vision correction to unlock your full visual potential.

Discover more: https://www.zeiss.com/vision-care/en/like-you/zeiss-vision-correction.html